[1]
K. A. Stroud and D. J. Booth, Foundation mathematics. Basingstoke: Palgrave Macmillan, 2009.
[2]
‘The Basics of MRI’. [Online]. Available: http://www.cis.rit.edu/htbooks/mri/inside.htm
[3]
P. Sprawls, Physical principles of medical imaging, 2nd ed. Gaithersburg, MA: Aspen, 1993 [Online]. Available: http://www.sprawls.org/ppmi2/
[4]
M. C. Diamond, A. B. Scheibel, and L. M. Elson, The human brain coloring book, 1st ed., vol. 306. New York: Barnes & Noble Books, 1985.
[5]
D. M. Yousem and R. Nadgir, Neuroradiology: the requisites, Fourth edition. Philadelphia, PA: Elsevier, 2017.
[6]
M. J. Campbell and T. D. V. Swinscow, Statistics at square one, 11th ed. Chichester: Wiley-Blackwell, 2009 [Online]. Available: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=2909755680004761&institutionId=4761&customerId=4760
[7]
‘Statistics at Square One | The BMJ’. [Online]. Available: https://www.bmj.com/about-bmj/resources-readers/publications/statistics-square-one
[8]
K. G. Gwathmey, T. M. Burns, M. P. Collins, and P. J. B. Dyck, ‘Vasculitic neuropathies’, The Lancet Neurology, vol. 13, no. 1, pp. 67–82, Jan. 2014, doi: 10.1016/S1474-4422(13)70236-9.
[9]
C. Salvarani, R. D. Brown, and G. G. Hunder, ‘Adult primary central nervous system vasculitis’, The Lancet, vol. 380, no. 9843, pp. 767–777, Aug. 2012, doi: 10.1016/S0140-6736(12)60069-5.
[10]
N. R. Evans, J. M. Tarkin, M. M. Chowdhury, E. A. Warburton, and J. H. F. Rudd, ‘PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology’, Current Atherosclerosis Reports, vol. 18, no. 6, Jun. 2016, doi: 10.1007/s11883-016-0584-3.
[11]
H. Manji, H. R. Jäger, and A. Winston, ‘HIV, dementia and antiretroviral drugs: 30 years of an epidemic’, Journal of Neurology, Neurosurgery & Psychiatry, vol. 84, no. 10, pp. 1126–1137, Oct. 2013, doi: 10.1136/jnnp-2012-304022.
[12]
D. B. Clifford and B. M. Ances, ‘HIV-associated neurocognitive disorder’, The Lancet Infectious Diseases, vol. 13, no. 11, pp. 976–986, Nov. 2013, doi: 10.1016/S1473-3099(13)70269-X.
[13]
I. L. Tan, B. R. Smith, G. von Geldern, F. J. Mateen, and J. C. McArthur, ‘HIV-associated opportunistic infections of the CNS’, The Lancet Neurology, vol. 11, no. 7, pp. 605–617, Jul. 2012, doi: 10.1016/S1474-4422(12)70098-4.
[14]
R. T. Johnson, Viral infections of the nervous system, 2nd ed. Philadelphia: Lippincott-Raven, 1998.
[15]
W. M. Scheld, R. J. Whitley, and C. M. Marra, Eds., Infections of the central nervous system, Fourth edition. Philadelphia: Wolters Kluwer Health, 2014 [Online]. Available: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=3197714180004761&institutionId=4761&customerId=4760
[16]
L. E. Davis and P. G. E. Kennedy, Infectious diseases of the nervous system. Oxford ; Boston: Butterworth-Heinemann, 2000.
[17]
J. Booss and M. M. Esiri, Viral encephalitis in humans. Washington, D.C.: ASM Press, 2003.
[18]
K. L. Tyler, ‘Acute Viral Encephalitis’, New England Journal of Medicine, vol. 379, no. 6, pp. 557–566, Aug. 2018, doi: 10.1056/NEJMra1708714.
[19]
J. Dalmau and F. Graus, ‘Antibody-Mediated Encephalitis’, New England Journal of Medicine, vol. 378, no. 9, pp. 840–851, Mar. 2018, doi: 10.1056/NEJMra1708712.
[20]
T. Solomon et al., ‘Management of suspected viral encephalitis in adults – Association of British Neurologists and British Infection Association National Guidelines’, Journal of Infection, vol. 64, no. 4, pp. 347–373, Apr. 2012, doi: 10.1016/j.jinf.2011.11.014.
[21]
K. L. Tyler, ‘Emerging Viral Infections of the Central Nervous System, part 1’, Archives of Neurology, vol. 66, no. 8, Aug. 2009, doi: 10.1001/archneurol.2009.153.
[22]
K. L. Tyler, ‘Emerging Viral Infections of the Central Nervous System, part 2’, Archives of Neurology, vol. 66, no. 9, Sep. 2009, doi: 10.1001/archneurol.2009.189.
[23]
N. Davies and G. Thwaites, ‘Infections of the nervous system’, Practical Neurology, vol. 11, no. 2, pp. 121–131, Mar. 2011, doi: 10.1136/jnnp.2011.242214.
[24]
D. van de Beek et al., ‘Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data’, The Lancet Neurology, vol. 9, no. 3, pp. 254–263, Mar. 2010, doi: 10.1016/S1474-4422(10)70023-5.
[25]
P. B. Barker, X. Golay, and G. Zaharchuk, Clinical perfusion MRI: techniques and applications. Cambridge: Cambridge University Press, 2013 [Online]. Available: http://ucl.alma.exlibrisgroup.com/view/action/uresolver.do?operation=resolveService&package_service_id=3202944840004761&institutionId=4761&customerId=4760
[26]
R. G. Nogueira et al., ‘Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct’, New England Journal of Medicine, vol. 378, no. 1, pp. 11–21, Jan. 2018, doi: 10.1056/NEJMoa1706442.
[27]
D. Saloner, ‘The AAPM/RSNA physics tutorial for residents. An introduction to MR angiography.’, RadioGraphics, vol. 15, no. 2, pp. 453–465, Mar. 1995, doi: 10.1148/radiographics.15.2.7761648.
[28]
S. Pandey, M. Hakky, E. Kwak, H. Jara, C. A. Geyer, and S. H. Erbay, ‘Application of Basic Principles of Physics to Head and Neck MR Angiography: Troubleshooting for Artifacts’, RadioGraphics, vol. 33, no. 3, pp. E113–E123, May 2013, doi: 10.1148/rg.333125148.
[29]
D. D. Cody, ‘AAPM/RSNA Physics Tutorial for Residents: Topics in CT’, RadioGraphics, vol. 22, no. 5, pp. 1255–1268, Sep. 2002, doi: 10.1148/radiographics.22.5.g02se041255.
[30]
J. A. Kaufman, D. McCarter, S. C. Geller, and A. C. Waltman, ‘Two-dimensional time-of-flight MR angiography of the lower extremities: artifacts and pitfalls.’, American Journal of Roentgenology, vol. 171, no. 1, pp. 129–135, Jul. 1998, doi: 10.2214/ajr.171.1.9648776.
[31]
A. Thapar, I. H. Jenkins, A. Mehta, and A. H. Davies, ‘Diagnosis and management of carotid atherosclerosis’, BMJ, vol. 346, no. mar18 1, pp. f1485–f1485, Mar. 2013, doi: 10.1136/bmj.f1485.
[32]
G.-M. von Reutern et al., ‘Grading Carotid Stenosis Using Ultrasonic Methods’, Stroke, vol. 43, no. 3, pp. 916–921, Mar. 2012, doi: 10.1161/STROKEAHA.111.636084.
[33]
‘RadioGraphics’ [Online]. Available: https://pubs.rsna.org/doi/10.1148/radiographics.15.1.7899596?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
[34]
‘AIUM Practice Guideline for the Performance of a Transcranial Doppler Ultrasound Examination for Adults and Children’, Journal of Ultrasound in Medicine, vol. 31, no. 9, pp. 1489–1500, Sep. 2012, doi: 10.7863/jum.2012.31.9.1489.
[35]
M. J. H. Aries, J. W. Elting, J. De Keyser, B. P. H. Kremer, and P. C. A. J. Vroomen, ‘Cerebral Autoregulation in Stroke’, Stroke, vol. 41, no. 11, pp. 2697–2704, Nov. 2010, doi: 10.1161/STROKEAHA.110.594168.
[36]
Patricia C. Davis, ‘Head Trauma’, American Journal of Neuroradiology, vol. 28, no. 8, pp. 1619–1621, Sep. 2007 [Online]. Available: http://www.ajnr.org/content/28/8/1619
[37]
J. J. Kim and A. D. Gean, ‘Imaging for the Diagnosis and Management of Traumatic Brain Injury’, Neurotherapeutics, vol. 8, no. 1, pp. 39–53, Jan. 2011, doi: 10.1007/s13311-010-0003-3.
[38]
A. D. Gean and N. J. Fischbein, ‘Head Trauma’, Neuroimaging Clinics of North America, vol. 20, no. 4, pp. 527–556 [Online]. Available: https://www.sciencedirect.com/search/advanced?docId=10.1016/j.nic.2010.08.001
[39]
T. A. Hijaz, E. A. Cento, and M. T. Walker, ‘Imaging of Head Trauma’, Radiologic Clinics of North America, vol. 49, no. 1, pp. 81–103, Jan. 2011, doi: 10.1016/j.rcl.2010.07.012.
[40]
AANS/CNS Joint Guidelines Committee, ‘Guidelines for the Management of Acute Cervical Spine and Spinal Cord Injuries: Congress of Neurological Surgeons’. [Online]. Available: https://www.cns.org/guidelines/guidelines-management-acute-cervical-spine-and-spinal-cord-injuries
[41]
‘Head injury: assessment and early management: Guidance and guidelines: NICE clinical guideline No. 176’. [Online]. Available: https://www.nice.org.uk/guidance/cg176
[42]
‘Spinal injury: assessment and initial management: Guidance and guidelines: NICE clinical guideline no. 41’. [Online]. Available: https://www.nice.org.uk/guidance/ng41
[43]
J. M. Wardlaw et al., ‘Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration’, The Lancet Neurology, vol. 12, no. 8, pp. 822–838, Aug. 2013, doi: 10.1016/S1474-4422(13)70124-8.
[44]
L. Pantoni, ‘Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges’, The Lancet Neurology, vol. 9, no. 7, pp. 689–701, Jul. 2010, doi: 10.1016/S1474-4422(10)70104-6.
[45]
D. van de Beek, J. de Gans, A. R. Tunkel, and E. F. M. Wijdicks, ‘Community-Acquired Bacterial Meningitis in Adults’, New England Journal of Medicine, vol. 354, no. 1, pp. 44–53, Jan. 2006, doi: 10.1056/NEJMra052116.
[46]
J. W. Gray, H. Ubhi, and P. Milner, ‘Antimicrobial Treatment of Serious Gram-Negative Infections in Newborns’, Current Infectious Disease Reports, vol. 16, no. 2, Feb. 2014, doi: 10.1007/s11908-014-0400-6.
[47]
R. L. DeBiasi, ‘A Concise Critical Analysis of Serologic Testing for the Diagnosis of Lyme Disease’, Current Infectious Disease Reports, vol. 16, no. 12, Dec. 2014, doi: 10.1007/s11908-014-0450-9.
[48]
‘Brain Abscess’, New England Journal of Medicine, vol. 371, no. 18, pp. 1756–1758, Oct. 2014, doi: 10.1056/NEJMc1410501.
[49]
I. L. Tan, B. R. Smith, G. von Geldern, F. J. Mateen, and J. C. McArthur, ‘HIV-associated opportunistic infections of the CNS’, The Lancet Neurology, vol. 11, no. 7, pp. 605–617, Jul. 2012, doi: 10.1016/S1474-4422(12)70098-4.
[50]
D. Bertholdo, A. Watcharakorn, and M. Castillo, ‘Brain Proton Magnetic Resonance Spectroscopy’, Neuroimaging Clinics of North America, vol. 23, no. 3, pp. 359–380, Aug. 2013, doi: 10.1016/j.nic.2012.10.002.
